Pfizer spin-out SpringWorks Therapeutics has its first approved product after getting a green light from the FDA for Ogsiveo, the first-ever therapy for a rare type of non-cancerous tumour that can ...
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...
Regulatory filing is supported by RINGSIDE showing an 84% reduction in progression or death risk versus placebo (HR 0.16; P<.0001) by blinded independent central review. Confirmed RECIST v1.1 ORR ...
New Drug Application (NDA) supported by positive Phase 3 RINGSIDE results, including significant improvement in progression-free survival vs. placebo (hazard ratio = 0.16, p<0.0001) Trial also met all ...
For a girl described as a dragon with fire in her veins, she sure can enter a room sweet as sugar. The school bus was pulling away from their Cole Harbour home as eight-year-old Harper Tanton walked ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results